Evaxion A (EVAX) EBITDA (2020 - 2026)
Evaxion A (EVAX) posted EBITDA of -$4.2 million for Q1 2026, up 53.18% quarter-over-quarter from -$8.9 million in Q4 2025, and down 7.99% year-on-year from -$4.5 million in Q1 2025.
Evaxion A (EVAX) EBITDA (2020 - 2026) Analysis & Trends
Evaxion A (EVAX) has reported EBITDA for 7 consecutive years, with -$4.2 million the latest figure, recorded in Q1 2026.
- EBITDA for Q1 2026 came in at -$4.2 million, down 7.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$9.4 million (up 1.64% YoY), and the FY2025 annual result was -$9.2 million, up 37.32% from the prior year.
- EBITDA was -$4.2 million for Q1 2026 at Evaxion A, up from -$8.9 million in the prior quarter.
- Over five years, EBITDA peaked at $3.0 million in Q3 2025 and troughed at -$8.9 million in Q4 2025.
- Average EBITDA over 5 years is -$4.2 million, with a median of -$4.4 million recorded in 2024.
- Year-over-year, EBITDA plunged 152175.0% in 2022 and soared 2289.29% in 2025.
- Over 5 years, EBITDA stood at -$6.5 million in 2022, then soared by 33.12% to -$4.4 million in 2023, then rose by 7.79% to -$4.0 million in 2024, then plunged by 121.72% to -$8.9 million in 2025, then jumped by 53.18% to -$4.2 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$4.2 million in Q1 2026, -$8.9 million in Q4 2025, and $3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | -106.00 Mn |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -14.44 Mn |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 249.90 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 1.14 Bn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -4.91 Mn |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 661.60 Mn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 394.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 201.19 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | -445.22 Mn |
| 10 | Evaxion A | 1.33 Bn | 1.33 Bn | - | -3.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.82 Mn |
| Dec 31, 2025 | -4.05 Mn |
| Sep 30, 2025 | 3.02 Mn |
| Jun 30, 2025 | 669,000.00 |
| Mar 31, 2025 | -3.87 Mn |
| Dec 31, 2024 | -4.02 Mn |
| Sep 30, 2024 | -1.73 Mn |
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | -4.40 Mn |
| Dec 31, 2023 | -4.36 Mn |
| Sep 30, 2023 | -5.76 Mn |
| Jun 30, 2023 | -5.68 Mn |
| Mar 31, 2023 | -6.53 Mn |
| Dec 31, 2022 | -6.53 Mn |
| Sep 30, 2022 | -6.08 Mn |
| Jun 30, 2022 | -6.37 Mn |
| Mar 31, 2022 | -6.39 Mn |
| Dec 31, 2021 | -7.72 Mn |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 6,000.00 |